Annexon, Inc(NASDAQ:ANNX) 
Annexon, Inc., a clinical-stage biopharmaceutical company, engages in developing therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its products in pipelines are focused on antibody-mediated autoimmune and complement-mediated neurodegenerative disorders....
Website: http://www.annexonbio.com
Founded: 2011
Full Time Employees: 38
CEO: Douglas Love
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.76
H 1.83
L 1.66
C 1.69
V 1,833,038
10EMA 1.69
20EMA 1.69
60EMA 1.69
120EMA 1.69
250EMA 1.69